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Jerusalem artichoke (Helianthus tuberosus Linne, HTL) and chungkookjang (CKJ; fermented soybeans) both modulate
energy and glucose metabolism. However, the mechanism and their additive effects are unknown. We investigated
whether the consumption of HTL and CKJ altered insulin sensitivity, insulin secretion capacity and β-cell survival in
type 2 diabetic animals. Rats were divided into partially pancreatectomized (Px) diabetic rats, and sham operated
non-diabetic control rats and all fed high fat diets. Diabetic rats were sub-divided into an untreated diabetic control
group and those fed 5% HTL, 5% CKJ or 5% HTL+5% CKJ for 8 weeks. HTL+CKJ treatment reduced visceral fat
without modulating energy intake compared to the diabetic-control. Glucose tolerance was improved in an
ascending order of diabetic-control, CKJ, HTL, HTL+CKJ, and normal-control, but by different mechanisms. CKJ and
CKJ+HTL, but not HTL, increased first and second phase insulin secretion in comparison to the diabetic-control at
hyperglycemic clamp. However, glucose infusion rates (mg/kg bw/min) were increased by and CKJ+HTL (13.5), but
not HTL (9.4) or CKJ (9.5) alone, and HTL and CKJ+ HTL decreased hepatic glucose compared to diabetic-control
during the hyperinsulinemic euglycemic study and were associated with decreased triglyceride accumulation and
increased glycogen storage. The improved hepatic insulin sensitivity by HTL and CKJ+HTL was explained by
potentiated insulin signaling (tyrosine phosphorylation of insulin receptor substrate 2→phosphorylation of Akt) and
phosphorylation of AMPK→phosphorykation of acetyl Co carboxlase in comparison to diabetic-control and
decreased PEPCK expression. Absolute β-cell mass was increased by CKJ (23.4mg) and CKJ+HTL (26.3 mg) by
increasing proliferation compared to the diabetic-control (21.26 mg). Although HTL lowered β-cell apoptosis, it did
not increase β-cell mass (20.8 mg). In conclusions, HTL and CKJ enhanced glucose tolerance in different manners,
and exhibited partially additive and complementary effects by reversing insulin resistance and enhancing β-cell
function in diabetic rats.
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East Asians have traditionally maintained good glycemic
control [1]. However, the incidence of diabetes is increasing
due to low quality diets early in life and greater consump-
tion of animal fats and less activity in later life [2,3]; changes
which exacerbate insulin resistance [3] and ultimately lead
to type 2 diabetes [2,4]. Insulin resistant Caucasians develop
hyperinsulinemia to maintain glucose intolerance which
delays the onset of type 2 diabetes [5]. However, East* Correspondence: smpark@hoseo.edu
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reproduction in any medium, provided the orAsians have lower insulin secretory capacity to compensate
for insulin resistance and therefore easily develop type 2
diabetes [4]. Therefore, preventing insulin resistance and
potentiating β-cell function and mass is even more impor-
tant for preventing type 2 diabetes in East Asians, since
they have little excess insulin secretory capacity to buffer
the effects of insulin resistance.
It is difficult to reverse modern dietary and lifestyle
trends, therefore it is important to identify dietary interven-
tions that can prevent or delay the onset of diabetes. We
previously reported that 8 week consumption of the
fermented soybean food, chungkookjang (20% of the diet),
increases β-cell function and mass and attenuates insulind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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kookjang had only a small effect on insulin sensitivity, so
foods that decrease insulin resistance would be a valu-
able addition to fermented soybeans. Jerusalem arti-
choke (Helianthus tuberosus Linne) is a native plant to
North America in the daisy family; its tubers are available
in the produce section of many grocery stores in worldwide
including Korea and are a common commercial source of
inulin. Jerusalem artichoke may improve insulin sensitivity
since inulin, its major component, decreases the synthesis
of triglycerides and fatty acids in the liver and lowers their
circulating levels in rats [8,9]. In addition, it decreases
fasting serum glucose levels in healthy humans [10], which
may be related to its fructan and coumarins such as ayapin
and scopletin [8]. The 20% chungkookjang used in the pre-
vious study is more than would be consumed in a typical
human diet. Therefore, the anti-diabetic effects of moderate
amounts of chungkookjang (soybeans fermented with
Bacilli spp.) and Jerusalem artichoke were determined
in type 2 diabetic rats and some of the potential
mechanisms explored.
Materials and methods
Chungkookjang and Jerusalem artichokes
Traditionally prepared Chungkookjang was manufac-
tured at Midari Farm (Yeongwol county, Kangwon-Do,
Korea). Cooked soybeans were fermented with Bacillus
spp. at 30°C for 43 h and then freeze-dried and powered
for adding into the diet. The process of making CKJ was
optimized for anti-diabetic activity based on previous
studies [11,12].
Since fructoligossacharides can be easily degraded into
free fructose by inulinase after harvesting, the Jerusalem
artichokes from Midari Farm (Yeongwol county) were
immediately sliced and steamed to inactivate inulinase,
and then dried at 60°C and powdered. The Jerusalem
artichoke used in this study contained less 4% of free
fructose of Jerusalem artichoke powder.
Isoflavonoids and peptides from chungkookjang and
fructoligosaccharides from Jerusalem artichokes
The lyophilized chungkookjang (CKJ) was extracted in
70% methanol containing 0.1% acetic acid; isoflavonoids
in the supernatant of the extracts were detected using
HPLC (PU 980, JASCO, Japan) equipped with an ODS
A303 (4.6 × 250 mm, 5 μm, YMC, USA) reversed phase
column and monitored at a wavelength of 254 nm with
a UV detector. Elution was carried out at a flow rate of
1.0 ml·min-1 with water and acetonitrile containing 0.1%
acetic acid. Peaks in each extract were identified by com-
paring to 12 reference isoflavonoids: genistein, daidzein,
and glycitein from Sigma Co. (St. Louis, MO); genistin,
daidzin, and glycitin from Indofine (Hillsborough, NJ);
and malonyl genistin, malonyl daidzin, malonyl glycitin,acetyl genistin, acetyl daidzin and acetyl glycitin from
LC Lab (Woburn, MA).
Peptide contents of chungkookjang were quantified using
a ninhydrin method described previously [13] and quanti-
fied using an external standard, L-leucine. The profiles of
peptides were determined by ultra performance liquid
chromatography (UPLC, Waters Co.) using Acquity UPLC
BEH C18 (2.1 × 100 mm, 1.7 μm; Waters, Milford, MA,
USA) and monitored at a wavelength of 220 nm using a
PDA detector. Elution was carried out at a flow rate of 0.35
ml·min-1 with gradient solution of 0.1% trifluroacetic acid
in water and 0.1% trifluroacetic acid in acetonitrile.
Dried Jerusalem artichokes (HTL) were extracted with
water at 95°C for 4 h and the extracts were filtered. The
filtrates were eluted in an HP-20 column (Supelco) and
concentrated with a vacuum evaporator. The concen-
trates were precipitated with 50% MeOH with inulin in
the precipitate and oligosaccharides in the supernatant,
which were measured by drying and weighing.
Animals and diets
Male Sprague Dawley rats, weighing 203±14 g, were
housed individually in stainless steel cages in a
temperature- and humidity-controlled environment (23°C
and 60%) on a normal 12 hour light–dark cycle. All surgical
and experimental procedures were performed in accor-
dance with the recommendations found in the Guide for
the Care and Use of Laboratory Animals published by the
National Institutes of Health, USA, and approved by the
Institutional Animal Care and Use Committee of Hoseo
University, Korea (2010–08). Mild type 2 diabetes was
induced by removing 90% of the pancreas using the
Hosokawa technique [14]. After 1 week of recovery,
the pancreatectomized (Px) rats were excluded from
the study if their random-fed serum glucose levels
were less than 7 mmol/L; the rats included in the study
had serum glucose levels of 9.4-11.8 mmol/L without
fasting. During the recovery period, the pancreas of Px
rats regenerate to about 50% of the original mass, and
their insulin secretory capacity was about 40-50%
lower than sham-operated (Sham) non-diabetic rats
that had the same operation as Px rats, except without
removing the pancreas. Px rats did not develop any
symptoms associated with nutrient malabsorption or
ketosis and the ratio of α- and β-cells was similar to
other type 2 diabetic animals. Therefore, Px rats exhi-
bited a similar phenotype to Asian type 2 diabetes charac-
terized by normal adiposity, insulin deficiency and insulin
resistance [14-16].
The Px rats were randomly assigned to four different
groups (diabetic-control, CKJ, CKJ+HTL, and HTL) of
20 animals. The diabetic-control and non-diabetic Sham
(normal-control) groups had a 40% energy high-fat diet
without chungkookjang and Jerusalem artichoke. All Px
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modified AIN-93 semi-purified diets for 8 wk [17]. CKJ,
CKJ+HTL and HTL diets contained 5% lyophilized chung-
kookjang, 5% lyophilized chungkookjang+5% lyophilized
Jerusalem artichoke, or 5% lyophilized Jerusalem artichoke,
respectively. Since CKJ and HTL contained a mixture of
carbohydrates, protein, and lipids, their compositions were
analyzed and the macronutrient compositions adjusted to
equal proportions by adding soybean oil and cellulose. All
diets consisted of approximately 42 energy percent (En%)
carbohydrates, 18 En% protein, and 40 En% fats (Table 1)
in order to study the effect of CKJ and HTL on insulin sen-
sitizing and insulinotropic actions under an aggravated
diabetic condition. The degree of hydrolysis of protein con-
centration, types of isoflavones and dietary fiber were the
main differences among diets. Isoflavonoid contents were
measured in our previous study; total isoflavonoids were
decreased but isoflavonoid aglycones increased during
fermentation (Table 1).
After 16 h overnight-fasting, serum glucose levels and
body weights of all experimental animals were measured
every Tuesday at 10 AM. To avoid fasting effects on
determining food intake, weighed feed was provided
each day and remaining food weighed the next, daily
feed intake was the average over one week. An oral glu-
cose tolerance test (OGTT) was performed every three
weeks in overnight-fasted animals by orally administe-
ring 2 g glucose/kg body weight. Serum glucose and
insulin were measured by tail bleeding at 0, 10, 20, 30,
45, 60, 90 and 120 min after glucose loading, and the
average of the area under the curve of serum glucose
and insulin was calculated. Serum glucose levels were




Corn starch (g) 300
Sucrose (g) 200
Cellulose (g) 34





Powder of CKJ (g) 0
Powder of HTL (g) 0
Total isoflavonoids (%) -
Isoflavonoid aglycones (%) -
Fructooligossaccharides including inulin (%)Alto, CA), and serum insulin and leptin levels were
measured by radioimmunoassay kit (Linco Research,
Billerica, MA).
Hyperglycemic clamp
After seven weeks of treatment, catheters were surgically
implanted into the right carotid artery and left jugular vein
of 10 rats from each group after anesthetization (ketamine
100 mg/kg bw and xylazine 10 mg/kg bw for all anesthesia).
After 5–6 days of implantation, a hyperglycemic clamp was
performed after 16 h fasting to determine insulin secretory
capacity as previously described [16,18]. During the clamp,
25% glucose solution was infused to maintain serum
glucose levels of 5.5 mM above baseline by measuring
Glucose Analyzer II (Beckman) at 0, 2, 5, 10, 60, 90 and
120 mins and at those times serum insulin levels were
measured by radioimmunoassay (Linco Research). After
the clamp, rats were freely provided with feed and water
for 2 days and the next day, they were fasted 16 hours,
anesthetized, and human regular insulin (5 U/kg body
weight) was injected through the inferior vena cava.
Ten min later, they were killed by decapitation and
tissues were rapidly collected, frozen in liquid nitrogen,
and stored at −70°C for further experiments.
Hyperinsulinemic euglycemic clamp
After catheterization on week 7, a hyperinsulinemic eugly-
cemic clamp was performed on 16 h-fasted conscious rats
from each group to determine insulin resistance as pre-
viously described [19]. [3-3H]glucose (NEN Life Science,
Boston, MA) was continuously infused during a 4-hour
period at the rate of 0.05 μCi·min-1. Basal hepatic glucose
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Then a primed continuous infusion of human regular
insulin (Humulin; Eli Lilly, Indianapolis, IN) was initiated
at a rate of 20 pmol·kg–1·min–1 to raise plasma insulin
concentration to approximately 1100 pM at 210 – 240
min. While infusing exogenous insulin and 25% glucose
solution, blood samples from arteries were collected at
10-minute intervals for glucose estimation by Glucose
Analyzer II (Beckman). Glucose solution was infused at
variable rates as needed to clamp euglycemia at approxi-
mately 6 mmol/L. For the determination of plasma [3-3H]
glucose concentrations, plasma was deproteinized with
ZnSO4 and Ba(OH)2, dried to remove
3H2O, re-suspended
in water, and disintegrations per min (dpm) of 3H were
recorded. The plasma concentration of 3H2O was deter-
mined by the difference between 3H counts with and with-
out drying. Rates of whole body glucose uptake and basal
glucose turnover were determined as the ratio of the [3H]
glucose infusion rate to the specific activity of plasma glu-
cose (dpm/μmol) during the final 30 minutes of the
respective experiments. Hepatic glucose production at
hyperinsulinemic clamped state was determined by sub-
tracting the glucose infusion rate from the whole body
glucose uptake.
Islet morphometry
Six rats from each group were treated with 5-bromo-2-
deoxyuridine (BrdU; Roche Molecular Biochemicals,
Indianapolis, Indiana, USA; 100 μg/kg body weight) at the
end of the 12-week experimental period. Six hours post-
injection, pancreas samples were prepared and analyzed
as previously described [16]. Each pancreas was dissected,
fixed in a 4% paraformaldehyde solution (pH 7.2) over-
night at room temperature, and embedded in paraffin
blocks. To prevent twice selecting sections (5-μm) with
the same islet, after rehydration every sixth or seventh
section was selected to determine β-cell area, BrdU
incorporation and cell death. Endocrine β-cells were
identified by applying a guinea pig anti-insulin anti-
body in paraffin-embedded pancreatic sections by immu-
nohistochemistry. Beta-cell areas were measured by
acquiring images from eight to ten distal, random, non-
overlapping images at × 20 of insulin stained pancreatic
sections and the area was measured by densitometery.
Results of β-cell quantification are expressed as the
percentage of the total surveyed pancreas area containing
insulin-positive cells. The β-cell mass was measured by
multiplying average β-cell area by pancreas weight. The α-
cells were determined by immunostaining with a rabbit
anti-glucagon in paraffin-embedded pancreatic section.
The ratio of β- and α-cells was calculated. Beta-cell prolif-
eration was examined by the incorporation of BrdU as
determined by performing a double-label immunohisto-
chemistry with anti-insulin (Zymed Laboratories, SouthSan Francisco, CA) and anti-BrdU antibodies (Roche,
Mannheim, Germany) on rehydrated paraffin sections. Cell
death of β-cells was measured by TUNEL kit (Roche) in
paraffin sections of the pancreas and counterstained with
hematoxylin and eosin to visualize islets [20].
Immunoblot analysis
Livers collected from rats stimulated with insulin for 10
min were lysed in 20 mM Tris buffer (pH 7.4) contai-
ning 2 mM EGTA, 137 mM NaCl, 1% NP40, 10% gly-
cerol, and 12 mM α-glycerol phosphate and protease
inhibitors. Immunoblotting was previously described [7].
Glycogen contents in the livers were determined by
centrifuging liver lysates at 4000 × g for 10 minutes after
which supernatants were deproteinized with 1.5 N
perchloric acid. The glycogen content was calculated
from glucose concentrations derived from glycogen
hydrolyzed by α-amyloglucosidase in an acid buffer [21].
Triacylglycerol was extracted with chloroform-methanol
(2:1, vol/vol) from the liver and resuspended in pure
chloroform [22]. After evaporating chloroform, the resi-
due was suspended with PBS and 0.1% triton X-100 and
the suspension was sonicated and boiled for 5 min. The
triacylglycerol contents of the suspensions were assayed
using a Trinder kit (Young Dong Pharm., Seoul, Korea).
Statistical analysis
Statistical analysis was performed using SAS software
and all results are expressed as mean±SD. Anti-diabetic
effects of Px-control, CKJ, HTL, CKJ+HTL and normal-
control were determined by one-way analysis of vari-
ance. Significant differences in the main effects among
groups were identified by Tukey tests. P<0.05 was
considered statistically significant.
Results
Isoflavonoids and fructan contents in HTL and CKJ
CKJ contained both isoflavonoid glycosides and aglycones,
with similar diadzein and daidzin concentrations but much
higher concentrations of genistein than genistin (Table 2).
HTL contained inulin and fructoligossacharides (Table 2).
HTL and CKJ lowers body weight and fasted glucose
concentrations
Body weight was higher in the rats of the normal-control
group than those of the diabetic groups despite lower en-
ergy intake but it was not significantly different among the
diabetic groups (Table 3). Unlike body weight, epididymal
fat pads and serum leptin levels decreased in a descending
order of normal-control > diabetic-control > CKJ, HTL >
CKJ+ HTL, although for epididymal fat pads the only sig-
nificant difference among diabetic rats was the lower CKJ
+HTL weights than diabetic-controls. Serum triglyceride
levels were higher in the diabetic-control group than the
Table 2 Isoflavonoids, peptides and fructoligossacharides (mg/g dry matter)
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and CKJ and the mixture of CKJ and HTL did not have an
additive effect on serum triglyceride levels. As expected,
rats in the normal-control had the lowest fasting serum
glucose levels while CKJ and HTL also had lower levels
than the diabetic-control and was lower in CKJ+HTL than
either alone. The overnight-fasted serum insulin levels were
higher in CKJ, but not HTL, compared to the diabetic-
control and rats in the CKJ+HTL group had higher levels
than those fed CKJ alone (Table 3). Thus, CKJ and HTL
lowered serum glucose levels in different manners. The
overnight-fasted serum glucagon levels of diabetic rats were
not significantly different from those of non-diabetic rats
and they were also not affected by CKJ or HTL (Table 3).
CKJ, HTL and CKJ+HTL improve glucose tolerance in
different manners
Rats in the diabetic-control had much higher peak
serum glucose levels which decreased slowly compared
to those in the normal-control (Figure 1A). In CKJ and
HTL and especially CKJ+HTL rats, peak serum glucose
levels were lower and decreased faster than controlsTable 3 Metabolic parameters after overnight-fasting
Diabetic-CON (n=20) CKJ (n=
Body weight (g) 337±47b 320±3
Epidydimal fat pads (g) 3.0±0.5b 2.7±0.4
Caloric intakes (Kcal/day) 115±18b 109±1
Serum triglyceride levels (mmol/L) 1.26±0.23a 1.01±0.
Serum leptin levels (ng/mL) 5.1±0.7b 4.3±0
Serum glucose levels (mmol/L) 9.8±1.4a 8.1±1.
Serum insulin levels (ng/mL) 0.69±0.13d 0.81±0
Serum glucagon (ng/mL) 95.4±10.3 92.5±1
Values are mean±SD. Rats in the normal-control (Normal-CON) and diabetic-control
CKJ+HTL groups were provided with high fat diets supplemented with 5% CKJ, 5%
*Significantly different among the groups at p<0.05 by one-way ANOVA.
a,b,c,dValues in the same row with different superscripts were significantly different i(Figure 1A). Diabetic-control rats exhibited much lower
serum insulin levels in first and second parts of OGTT
than normal-control rats (Figure 1B). Area under the
curve (AUC) of insulin in the first part was higher in
ascending order of the diabetic-control < CKJ < HTL
< CKJ+HTL < normal-control whereas in CKJ+HTL and
HTL it decreased in the second part, but not with CKJ
alone and normal-control. As the changes in serum glucose
levels were associated with insulin secretion and insulin
action, only CKJ increased serum insulin levels in both first
and second parts of OGTT (Figure 1B), indicating that CKJ
and HTL improved glucose tolerance differently.
CKJ potentiates insulin secretion capacity during
hyperglycemic clamp
In comparison to those in the normal-control group,
rats in the diabetic-control group had lower first and
second phase insulin secretion by 60.4% and 51.9%,
respectively, during hyperglycemic clamp. CKJ and HTL
increased first phase insulin secretion more than the
diabetic-control and CKJ+HTL elevated it more than
CKJ or HTL alone (Figure 2 & Table 4). However, CKJ20) HTL (n=20) CKJ+HTL (n=20) Normal-CON (n=20)
8b 324±33b 317±39b 427±39a*
bc 2.7±0.4bc 2.4±0.4c 4.6±0.7a*
7b 110±16b 105±17b 93±14a*
12b 0.98±0.14b 0.97±0.15b 0.93±0.13b*
.6c 4.4±0.6c 3.6±0.6d 6.6±0.8a*
0b 7.7±0.9b 6.3±0.8c 4.3±0.7d*
.13c 0.66±0.11d 1.02±0.16b 1.38±0.24a*
1.7 91.7±12.1 91.5±10.9 90.4±11.5
(Diabetic-CON) was fed high fat diets while diabetic rats in the CKJ, HTL, and
HTL, and 5% CKJ+ 5% HTL, respectively.
n Tukey test at P<0.05.
Figure 1 Serum glucose levels (A) and the area under the curve of serum glucose and insulin (B) during oral glucose tolerance tests.
Serum glucose time course (A) and area under the curve (AUC) for glucose and insulin in non-diabetic Sham and diabetic Px rats fed high fat
diets with casein (normal-control and diabetic-control groups, respectively), 5% CKJ, 5% HTL, or 5% CKJ+ 5% HTL for 8 wk, following oral loading
with 2 g glucose per kg bw. Normal-CON group represented non-diabetic Sham rats fed high fat diets with casein. The sample size was the same
as in Table 3. The bars represent mean±SD. *Significantly different among the groups at p<0.05 by one-way ANOVA. a,b,cValues in the same row
with different superscripts were significantly different in Tukey test at P<0.05.
Figure 2 Insulin secretion capacity during hyperglycemic clamp. Serum insulin levels were measured during hyperglycemic clamp in
diabetic Px rats fed high fat diets with casein (diabetic-CON group), 5% CKJ, 5% HTL, or 5% CKJ+ 5% HTL for 8 wk. Normal-CON group
represented non-diabetic Sham rats fed high fat diets with casein. The sample size was the same as in Table 4. *Significantly different among the
groups at p<0.05 by one-way ANOVA. a,b,cValues in the same row with different superscripts were significantly different by Tukey test at P<0.05.
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Serum insulin at basal state 0.72±0.13d 0.84±0.11c 0.69±0.10d 1.07±0.16b 1.36±0.26a*
Serum insulin at first phase (ng/mL) 1.56±0.23d 2.03±0.28c 1.86±0.31c 2.50±0.38b 3.94±0.65a*
Serum insulin at second phase (ng/mL) 1.81±0.31c 2.16±0.35b 1.80±0.28c 2.33±041b 3.76±0.67a*





Glucose infusion rate (mg/kg bw/min) 8.3±1.2d 9.5±1.2c 9.4±1.2c 13.5±1.5b 25.5±3.4a*
Insulin sensitivity (μmol glucose · min-1 · 100 g-1 per μmol
insulin/L)
12.4±1.5c 11.9±1.7c 14.1±1.7bc 15.6±1.8b 18.3±2.6a*
Values are mean±SD. First phase insulin secretion was defined as the average of serum insulin levels at 2 and 5 mins, with second phase at 60, 90 and 120 mins.
Insulin sensitivity at hyperglycemic state was calculated as the ratio of glucose infusion rates to steady-state serum insulin levels. Rats in the normal-control
(Normal-CON) and diabetic-control (Diabetic-CON) was fed high fat diets while diabetic rats in the CKJ, HTL, and CKJ+HTL groups were provided with high fat
diets supplemented with 5% CKJ, 5% HTL, and 5% CKJ+ 5% HTL, respectively.
*Significantly different among the groups at p<0.05 by one-way ANOVA.
a,b,c,dValues in the same row with different superscripts were significantly different in Tukey test at P<0.05.
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insulin secretion and AUC of insulin during hyperglycemic
clamp in comparison to the diabetic-control. Glucose infu-
sion rates required to maintain serum glucose levels above
5.5 mM were decreased in a descending order of normal-
control > CKJ+HTL > CKJ, HTL and diabetic-control. In
addition, insulin sensitivity during hyperglycemic state
exhibited the same trend of glucose infusion rates but insu-
lin sensitivity of rats in the HTL group was higher than that
in the diabetic-control group and CKJ+HTL was improved
the sensitivity as much as the normal-control (Table 4).
CKJ increases β-cell mass
The β-cell areas were increased in order of normal-
control, diabetic-control, HTL, CKJ and CKJ+HTL since
diabetic rats needed more β-cells for regenerating the
pancreas (Table 5). When calculating β-cell mass by
multiplying β-cell area by pancreas weight, β-cell mass
was greatest in the normal-control group since pancreas
weights of Px rats were about 40-50% of the original
(data not shown). The β-cell mass of rats in the
diabetic-control group was 64±7.6% less than in the
normal-control group. The changes in β-cell area in Px
rats was related to increased β-cell proliferation inTable 5 The modulation of islet morphometry
Diabetic-CON (n=7) CKJ
β-cell area (%) 6.4±0.7b 7.0
Individual β-cell size (μm2) 242.4±31.1a 221.3
Absolute β-cell mass (mg) 21.1±2.6c 23.4
BrdU+ cells (% BrdU+ cells of islets) 0.83±0.10c 0.95
Apoptosis (% apoptotic bodies of islets) 0.73±0.08a 0.68
Ratio of β:α cells 4.6±0.5b 5.8
Values are mean±SD. Rats in the normal-control (Normal-CON) and diabetic-control
CKJ+HTL groups were provided with high fat diets supplemented with 5% CKJ, 5%
*Significantly different among the groups at p<0.05 by one-way ANOVA.
a,b,cValues in the same row with different superscripts were significantly different incomparison to Sham rats (Table 5). The normal-control
group exhibited less β-cell proliferation than the
diabetic-control group while CKJ and CKJ+HTL exhib-
ited increased β-cell proliferation in comparison to the
diabetic-control group. However, normal-control, HTL
and CKJ+HTL had decreased β-cell apoptosis in com-
parison to the diabetic-control. The ratio of β:α cells
was lower in the diabetic-control group than the
normal-control group, indicating that pancreatectomy
induced α-cell infiltration into β-cells in islets (Table 5
and Figure 3). CKJ, HTL and CKJ+HTL elevated the
ratio of β:α cells compared to the diabetic-control. This
indicated that in diabetic rats, CKJ+HTL attenuated
α-cell infiltration and improved islet morphometry to
resemble normal-control.
HTL attenuates insulin resistance
During hyperinsulinemic euglycemic clamp, glucose infu-
sion rates and whole body glucose uptake at about 1100
pM serum insulin levels were lower in rats in the diabetic-
control group than the normal-control group (Figure 4).
Hyperinsulinemic euglycemic clamp was performed to
determine whether the improved glucose tolerance of CKJ,
HTL and CKJ+HTL administered rats was associated with(n=7) HTL (n=7) CKJ+HTL (n=7) Normal-CON (n=7)
±0.7ab 6.6±0.7b 7.8±0.8a 5.6±0.7c*
±25.4ab 215.6±24.7b 190.5±25.4b 182.2±26.8b*
±2.7bc 22.8±2.5c 26.3±2.8b 34.6±4.8a*
±0.11b 0.86±0.12bc 1.15±0.13a 0.74±0.09c*
±0.08ab 0.65±0.08b 0.60±0.07b 0.65±0.10b*
±0.6b 5.6±0.6b 6.3±0.7a 6.0±0.8a*
(Diabetic-CON) was fed high fat diets while diabetic rats in the CKJ, HTL, and
HTL, and 5% CKJ+ 5% HTL, respectively.
Tukey test at P<0.05.
Figure 3 Islet morphometry representing β-cells and α-cells. At the end of experiment, the α-cells were determined by immunostaining with
a rabbit anti-glucagon in paraffin-embedded pancreatic section. Green and red were immunostained with anti-insulin and anti-glucagon,
respectively and they are represented as β-cells and α-cells, respectively.
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http://www.nutritionandmetabolism.com/content/9/1/112ameliorated insulin resistance. The different diets did not
alter whole body glucose uptake among the diabetic groups
but HTL and CKJ+HTL significantly increased glucose in-
fusion rates (Figure 4). Taken together the glucose infusion
rates and whole body glucose uptake, hepatic glucose out-
put at hyperinsulinemic state was lowered in a descending
order of the diabetic-control, CKJ > HTL > CKJ+HTL >
normal-control (Figure 4).
CKJ and HTL improve hepatic insulin signaling
Glycogen accumulation was higher in the normal-control
group than the diabetic-control group (Figure 5A), whereas
in diabetic rats HTL and CKJ+HTL increased glycogen
storage in the liver, in comparison to the diabetic-control
group. Triglyceride storage deceased in descending order ofFigure 4 Metabolic parameters during a euglycemic hyperinsulinemic
conscious, free moving and overnight fasted diabetic rats fed high fat diets
CKJ+5% HTL, for 8 wks to determine whole body insulin resistance. Norma
with casein. Glucose infusion rates (GIR), whole body glucose uptake, and h
The sample size was the same as in Table 4. *Significantly different among
row with different superscripts were significantly different in Tukey test at Pdiabetic-control > CKJ, HTL > CKJ+HTL > normal-control.
Thus, CKJ+HTL partially normalized hepatic storage of
glycogen and triglyceride, approaching that of the normal-
control group (Figure 5A).
β-Actin normalized tyrosine phosphorylation of insulin
receptor substrate-2 (IRS2), which is the first protein to
transmit the insulin receptor signal, was increased with
CKJ, HTL, and CKJ+HTL. However, the tyrosine phos-
phorylation of IRS2 based on IRS2 expression was higher
in HTL and CKJ+HTL than the control, but it was not
changed with CKJ since IRS2 expression exhibited an
increase with CKJ and CKJ+HTL (Figure 5B). Consistent
with tyrosine phosphorylation of IRS2, the phosphorylation
of Akt, a downstream effector of insulin receptor signaling,
was potentiated in the ascending order of diabetic-control,clamp. Euglycemic hyperinsulinemic clamp was performed in
supplemented with casein (diabetic-CON), 5% CKJ, 5% HTL, and 5%
l-CON group represented non-diabetic Sham rats fed high fat diets
epatic glucose output at basal and clamped states were determined.
the all groups at p<0.05 by one-way ANOVA. a,b,c,dValues in the same
<0.05.
Figure 5 (See legend on next page.)
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Figure 5 Glycogen and triglyceride accumulation and insulin signaling in the liver at the end of experiment. After 8 wk of feeding
diabetic rats from each group fed high fat diets with casein (diabetic-CON), 5% CKJ, 5% HTL, or 5% CKJ+5% HTL, the liver was collected after
injecting with insulin (5 U/kg body weight) for 10 min and lyzed with designated buffer. Hepatic glycogen and triglyceride contents (A), hepatic
insulin signaling (B) and AMPK signaling (C) were determined. Normal-CON group represented non-diabetic Sham rats fed with the casein diet.
PEPCK, phosphoenolpyruvate carboxykinase. *Significantly different among the all groups at p<0.05 by one-way ANOVA. a,b,c,dValues in the same
row with different superscripts were significantly different in Tukey test at P<0.05.
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improved hepatic insulin signaling the most (Figure 5B).
The expression of phosphoenolpyruvate carboxykinase
(PEPCK), the key regulator of gluconeogenesis, was
decreased in the descending order of diabetic-control, CKJ,
HTL, and CKJ+HTL (Figure 5B). The expressions of glu-
cose transporter-2 (GLUT2) and glucokinase were also
increased in CKJ, HTL and CKJ+HTL in comparison to
the diabetic-control (Figure 5B).
AMPK phosphorylation, an intracellular energy gauge,
exhibited an ascending order of increase in control
< CKJ=HTL < CKJ+HTL (Figure 5C). In addition, the
phosphorylation of acetyl CoA carboxylase (ACC), a me-
diator of AMPK downstream, was consistent with AMPK.
Discussion
Jerusalem artichoke is high in fructoligosacharides
whereas chungkookjang is rich in isoflavonoid aglycones
and small peptides. Large dosages of chungkookjang
reportedly exert anti-diabetic effects by potentiating
glucose-stimulated insulin secretion and attenuating in-
sulin resistance [5,7]. In addition, Jerusalem artichoke
had anti-diabetic effects due to high in fructoligossa-
charides that may decrease insulin resistance by mecha-
nisms that remain unknown. Since chungkookjang and
Jerusalem artichoke may have different anti-diabetic
mechanisms it is worth evaluating their combined effects.
In the present study, HTL and CKJ improved glucose toler-
ance differently in diabetic rats, and when combined they
remarkably enhanced glucose homeostasis in Px rats, type
2 diabetic rats. After removing 90% of the pancreas, the
pancreas is regenerated up to 40-50% of the intact pancreas
and insulin secretion capacity is about 50-60% of the non-
diabetic rats. Thus, Px rats are non-obese and moderate
type 2 diabetic animal model. Px rats exhibited a similar
phenotype to Asian type 2 diabetes, which has specific
characteristics of non-obesity and high susceptibility to in-
sulin deficiency with increased insulin resistance [14-16].
Rather than becoming hyperglycemic, Asians with insulin
resistance exhibit normal insulin levels or hypoinsulinemia,
and easily progress from glucose intolerance to type 2 dia-
betes [16]. Px rats are a good model to study β-cell expan-
sion and the relationship between β-cell function and
insulin resistance since they are a non-obese type 2 diabetic
model with characteristics relevant to Asian type 2
diabetes.HTL contains fructan which is largely comprised of
inulin and oligofructose. Fructan is a non-digestible fiber
with health benefits [23-25]. It selectively stimulates the
growth and/or activity of some beneficial bacteria in the
colon and represses the growth of pathogens [8]. How-
ever, the effects of inulin and oligofructose on glucose
metabolism are not fully understood and the available
data are contradictory. Recently, Dewulf et al. [26,27]
revealed that inulin-type diets counteract high-fat diet-
induced obesity via suppressing G protein-coupled re-
ceptor-43 overexpression through the modification of
the gut microbiota and they resulted in a decreased level
of circulating lipopolysaccharide and lower C-reactive
protein levels to attenuate inflammation. Therefore, the
prebiotics such as oligofractan in HTL might reduce sys-
temic inflammation which could be protective against
diabetes. Since CKJ contains beneficial Bacillus that can
use oligofructan in HTL as an energy source, the com-
bination of CKJ and HTL may have a synergistic effect.
Some studies have found that in diabetic rats, 10-20%
oligofructose diets decrease postprandial glycemia, but
the results for serum insulin levels were inconsistent [8].
In healthy humans, 20 g/d oligofructan does not alter
fasting serum glucose levels, but in diabetics, 8 g/d
oligofructan lowers glucose levels [10,24]. However,
Aslan et al. [25] found that 80% ethanol extracts (500
mg/kg body weight) did not improve blood glucose
levels after glucose load, perhaps due to higher contents
of free fructose resulting from improper storage condi-
tions [28,29]. Improperly stored HTL can break down
into simple sugars and exacerbate diabetic symptoms.
We found that 5% HTL extracts marginally improved
glucose metabolism (data not shown).
Besides lowering postprandial glycemia, oligofructan
reduces hepatic gluconeogenesis in normal subjects [10],
which may be mediated by short-chain carboxylic acids,
especially propionates, made by intestinal microbes from
inulin. Boillot et al. [9] reported that propionate con-
sumption reduced fasting blood glucose levels in rats. In
addition, propionates inhibit gluconogensesis in isolated
hepatocytes when converted into methyl malonyl CoA
and succinyl CoA which inhibit pyruvate carboxylase
activity. In consistent with other study about oligofruc-
tans [10], the present study revealed that HTL improved
hepatic insulin sensitivity by enhancing insulin signaling
in the liver.
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dependent insulinotropic peptides and glucagon-like
peptides (GLP-1), regulating post-prandial insulin release
and potentiating insulin action by two-fold in rats [30].
However, it is controversial. Parnell and Reimer [31]
reported that oligofructan supplementation (21 g/day)
for 12 weeks decreased body weight by lowering food
intake and serum glucose levels in obese adults but
serum GLP-1 levels were not altered. The increased
serum GLP-1 levels by oligofructans might be related to
the tropic action of short-chain fatty acids produced by
colonic oligofructan fermentation. However, in the
present study HTL did not change glucose-stimulated
insulin secretion and β-cell mass in diabetic rats, but
HTL+CKJ additively improved insulinotropic action
suggesting that HTL may have enhanced the action of
chungkookjang. Thus, the anti-diabetic effects of HTL
were related to enhanced insulin signaling decreasing
hepatic gluconeogenesis, probably due to fructan in
HTL. The different results may be due to the amount of
oligofructan contents in the HTL diet. However, we cannot
eliminate the possibility of stronger anti-diabetic effects
with higher dosages of oligofructan from Jerusalem
artichoke.
We previously demonstrated that chungkookjang
exerts insulinotropic action, potentiating glucose-
stimulated insulin secretion and increasing β-cell mass
by elevating β-cell proliferation and decreasing apop-
tosis [6]. GLP-1 secreted from the intestinal L-cells
increases insulin secretion from β-cells and expands
β-cell mass after meals. GLP-1 or exendin-4, a GLP-1
receptor agonist, potentiates insulinotropic action by
enhancing insulin/IGF-1 signaling in β-cells through
increasing intracellular cAMP→ phosphorylation of cAMP
responding element binding protein (CREB) →IRS-1 pro-
tein expression [32,33]. Genistein enhances insulino-
tropic action in β-cells by activating cAMP→CREB
phosphorylation→ tyrosine phosphorylation of IRS2
[34,35]. In addition, isoflavnoids support glucose
management through estrogen-like actions. Estrogen is
reported to improve glucose homeostasis by potentiat-
ing glucose-stimulated insulin secretion and attenuates
insulin resistance [16].
Soy protein also limits the accretion of visceral adiposity
and increased peroxisome proliferator-activated receptor
(PPAR)-γ and GLUT4 expressions, improving glucose
metabolism in Wistar rats fed sucrose-rich diets [36]. Soy
protein including isoflavonoids partially prevents insulin
resistance, steatosis, and hypercholesterolemia in rats fed
Western diets by reducing the expression of enzymes
related to fatty acid synthesis such as nuclear sterol recep-
tor element binding protein-1c and by increasing the
proteins associated with fatty acid degradation such as
PPAR-α [35]. However, Gobert et al. [37] reported that soyprotein isolates do not significantly affect fasting or post-
prandial glucose or insulin, fasting HbA1C, or indices of in-
sulin sensitivity. Thus, it remains unclear if soy protein has
anti-diabetic effects. Our previous in vitro study demon-
strated that water extracts of chungkookjang, containing
mostly peptides, greatly increase insulin-stimulated glucose
uptake compared to soybeans by increasing PPAR-γ
expression [38]. The increase by water extracts is much
greater than the methanol fraction of chungkookjang
containing isoflavonoid [38], suggesting that peptides in
chungkookjang are better for improving insulin resistance
than those in soybeans.
Conclusions
CKJ and HTL both had potent, but different, anti-diabetic
effects in diabetic rats: CKJ potentiated glucose-stimulated
insulin secretion and increased β-cell mass best, whereas
HTL improved insulin sensitivity better than CKJ. CKJ
+HTL exhibited partial additive and complementary anti-
diabetic effects by potentiating insulinotropic action and
reducing insulin resistance in diabetic rats.
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